Table 2.

Diagnostic exams

Clinical Features	Healthy	Diabetic		P-value*
	(N=51)	w/o AMI (N=150)	w/AMI (N=108)
	Group 1	Group 2	Group 3
Total cholesterol (mg/dL)
Mean ± SD	185.9 ± 33.4	192.8 ± 40	144.7 ± 34.2	<0.001
HDL (mg/dL)
Mean ± SD	62.7 ± 18.2	49.7 ± 16.2	41 ± 11.1	<0.001
LDL (mg/dL)
Mean ± SD	102.5 ± 32.6	110.6 ± 32.2	76.3 ± 28.6	<0.001
Triglycerides (mg/dL)
Mean ± SD	113.5 ± 105.1	203.4 ± 178	181.9 ± 111.2	<0.001
C-Protein Reactive (mg/dL)
Mean ± SD	1.5± 0.2	4.7± 0.5	4.2± 1.6	<0.001
HbA1c (%)
Mean ± SD	5.1 ± 0.3	8.3 ± 2	7.6 ± 1.9	<0.001
Hemoglobin (g/dL)
Mean ± SD	13.9 ± 1.3	14.1 ± 1.6	13.6 ± 1.6	0.044
Insulin (mUI/mL)
Mean ± SD	10.7 ± 7.8	28.4 ± 25.7	21.9 ± 25.1	<0.001
GFR (mL/min/1,73m2)
Mean ± SD	101.4 ± 22.4	99.9 ± 28.5	82.6 ± 24.4	<0.001
Cardiac MRI	(N=51)	(N=114)	(N=45)	P-value*
Left Ventricle EF (%)	#
Mean ± SD	68.9 ± 4.2	65.4 ± 8	62.5 ± 10.4	0.138
Right Ventricle EF
Mean ± SD	-	62.4 ± 6.6	63.7 ± 8.8	0.219
LV End-Diastolic Diameter (cm)
Mean ± SD	4.6 ± 0.4	4.9 ± 0.6	5 ± 0.8	0.019
LV Systolic Diameter (cm)
Mean ± SD	2.8 ± 0.3	3.1 ± 0.6	3.5 ± 1	0.001
Retinography	(N=50)	(N=144)	(N=54)	P-value*
Absent	50 (100%)	99 (69%)	35 (64%)	<0.001
Non-proliferative	0 (0%)	40 (28%)	15 (28%)
Proliferative	0 (0%)	5 (3%)	4 (7%)
6-Month Follow-up	(N=50)	(N=144)	(N=54)	P-value*
Quality of Life (EQ-5D)	5.6 ± 0.8	6.9 ± 1.5	7.0 ± 1.9	<0,001
MACCE	0 (0%)	1 (0.6%)	0 (0%)	0.126

GFR Glomerular filtration rate, MRI Magnetic resonance imaging, EF Ejection Fraction, SD Standard deviation

# Healthy group performed echocardiogram

MACCE Major cardiovascular and cerebrovascular adverse event

*P-Value signiifcant (<0.05)